- Impact Biomedical Inc.
Impact Biomedical Inc.
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$3.00
1,500,000
Positive
High
13.59%
Offering Team
Deal Managers
- Revere Securities
Lawyers
- Lucosky Brookman LLP
Auditors
- Turner, Stone & Company, L.L.P.
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Impact Biomedical Inc. (IBIO) is a subsidiary of DSS Inc (DSS: NYSE). IBIO discovers, confirms, and patents unique science and technologies which can be developed into new offerings in human healthcare and wellness in collaboration with external partners through licensing, co-development, joint ventures, and other relationships. More
Deal Tracker
Investors
Filing
17 Oct, 2023Offer
16 Sep, 2024Look Ahead
Lock Up Expiry
16 Mar, 2025Earning
Nov 1, 2018IPO Terms
| Offer Price | $3.00 |
| Offer Size | 1M |